The story of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the pharmaceutical landscape . Although its groundbreaking success and impact of countless in revenue , the intellectual property expiration has opened the door for competing medications, greatly reducing profit prospects . This transiti